Every successful Plasmodium falciparum culture begins long before parasites are seen under the microscope.
It begins with a blood draw.
Researchers often spend considerable time optimising culture media, adjusting gas mixtures, monitoring parasitaemia, and maintaining incubators. Yet one of the most overlooked factors affecting malaria culture success happens within seconds of collecting blood from a donor.
The choice of blood collection tube.
Why do malaria laboratories routinely collect donor blood into ACD-A blood collection tubes instead of ordinary collection tubes? Why is the tube filled completely? Why must it be mixed immediately after collection? And why can something as simple as a small blood clot compromise an otherwise perfectly planned experiment?
The answers lie in the chemistry of blood coagulation and the biology of the red blood cell.
Understanding what happens inside an ACD-A blood collection tube not only improves specimen quality but also explains why this anticoagulant has become one of the preferred choices for preserving healthy red blood cells used in Plasmodium falciparum culture.
In this article, we'll explore the science behind ACD-A, how it prevents blood clotting, why it helps preserve red blood cell function, and why proper blood collection is the foundation of successful malaria culture.
Why Fresh Red Blood Cells Matter
If you've worked in a mammalian cell culture laboratory, you're probably familiar with growing cells such as HEK293, CHO, or HeLa cells. These cells are maintained in specialised culture media that provide amino acids, vitamins, glucose, salts, growth factors, and appropriate physiological conditions. Given the right nutrients and environment, they divide continuously, allowing researchers to maintain the same cell line for months or even years.
Plasmodium falciparum culture is fundamentally different.
Although the parasite is supplied with a nutrient-rich culture medium, it cannot grow in the medium alone. Instead, every parasite must invade a living human red blood cell to complete the asexual stage of its life cycle.
Unlike mammalian cells grown in tissue culture flasks, mature human red blood cells do not divide. They lack a nucleus, mitochondria, ribosomes, and most other intracellular organelles. Once collected from a donor, they cannot be expanded or replaced by cell division. As red blood cells age, they gradually lose membrane flexibility, undergo biochemical changes, and eventually become unsuitable for parasite invasion.
For this reason, malaria laboratories must routinely obtain fresh donor red blood cells to maintain continuous P. falciparum cultures. These erythrocytes serve as the parasite's host cell, providing the environment in which merozoites invade, develop through the ring, trophozoite, and schizont stages, and eventually produce a new generation of invasive parasites.
Maintaining healthy red blood cells is therefore just as important as preparing the correct culture medium. Even if every other component of the culture system is optimised, poor-quality erythrocytes will limit parasite growth and compromise experimental reproducibility.
However, collecting fresh blood introduces an immediate challenge.
Blood naturally wants to clot.
Why Blood Clots Outside the Body
If you've ever accidentally cut your finger while working in the laboratory or at home, you've witnessed one of the body's most remarkable defence mechanisms.
Within seconds, the bleeding begins to slow.
Within minutes, a clot forms.
What appears to be a simple scab is actually the result of one of the most complex biochemical pathways in human physiology.
Blood clotting, also known as haemostasis, is an essential survival mechanism. Without it, even minor injuries could result in life-threatening blood loss. Throughout evolution, mammals have developed an intricate system of enzymes, platelets, and plasma proteins that work together to seal damaged blood vessels almost immediately after injury.
Ironically, the same mechanism that protects us becomes a major obstacle once blood is collected for laboratory use.
The moment blood leaves the circulatory system, it is exposed to artificial surfaces such as collection needles, plastic tubing, and blood collection tubes. These surfaces, together with the absence of the protective lining of blood vessels, activate the coagulation cascade.
Platelets begin adhering to one another and release signalling molecules that recruit additional platelets to the site.
At the same time, a series of inactive clotting proteins, known as coagulation factors, are activated sequentially in what biochemists often describe as a proteolytic cascade. Each activated factor activates the next, amplifying the response until large amounts of thrombin are produced.
Thrombin is one of the central enzymes in blood coagulation.
Its primary role is to convert fibrinogen, a soluble protein circulating in plasma, into fibrin, an insoluble fibrous protein.
Individual fibrin molecules then polymerise to form long strands that intertwine into a dense meshwork.
This fibrin mesh acts like a biological fishing net, trapping red blood cells, platelets, and other blood cells to produce a stable blood clot.
For wound healing, this process is indispensable.
For malaria research, it is disastrous.
Once fibrin forms, healthy erythrocytes become trapped within the clot, making them difficult or impossible to recover for parasite culture. Even small fibrin clots can reduce the number of usable red blood cells, interfere with washing procedures, and introduce variability between experiments.
The challenge, therefore, is not simply to collect blood.
It is to interrupt the clotting cascade before fibrin ever has a chance to form.
This is precisely why anticoagulants are added to blood collection tubes.
But how do anticoagulants stop one of the body's most powerful defence mechanisms?
To answer that, we first need to look at one of the smallest yet most important ions in blood chemistry: calcium.
Calcium: The Unsung Hero of Blood Clotting
If you ask someone what calcium does in the body, they'll probably mention bones and teeth.
They'd be right.
Approximately 99% of the body's calcium is stored in the skeleton, providing structural support and serving as a reservoir for this essential mineral.
But the remaining 1% performs a remarkable variety of functions throughout the body.
Calcium ions (Ca²⁺) are involved in muscle contraction, nerve impulse transmission, hormone secretion, enzyme regulation, and intracellular signalling. Every heartbeat, every muscle movement, and every nerve impulse depends, in some way, on calcium.
Blood clotting is no exception.
In fact, calcium is so essential to coagulation that it is historically known as Coagulation Factor IV.
Unlike most clotting factors, which are proteins synthesised by the liver, calcium is a simple mineral ion. Yet without it, the coagulation cascade grinds to a halt.
Why?
Many of the proteins involved in blood coagulation require calcium to function properly. Calcium acts as a molecular bridge, allowing clotting factors to bind to negatively charged phospholipid surfaces exposed on activated platelets. These surfaces serve as platforms where multiple clotting factors assemble into highly efficient enzyme complexes.
Without calcium, these complexes cannot form.
As a result, several critical reactions in the coagulation cascade slow dramatically or fail altogether.
One of the most important of these reactions is the conversion of prothrombin (Factor II) into thrombin (Factor IIa).
Thrombin is often described as the master enzyme of coagulation because it converts soluble fibrinogen into insoluble fibrin strands, ultimately producing the fibrin mesh that stabilises a blood clot.
Remove calcium from the equation, and thrombin production falls dramatically.
Without sufficient thrombin, fibrin cannot form.
Without fibrin, there is no stable blood clot.
This dependence on calcium provides laboratory scientists with an elegant solution.
Rather than trying to inhibit every individual clotting enzyme, why not simply remove the calcium that they all depend upon?
That is precisely the strategy used by citrate-based anticoagulants.
What Is ACD-A?
ACD stands for Acid Citrate Dextrose.
It is one of several citrate-based anticoagulant formulations developed to preserve whole blood outside the body. Although different formulations exist—including ACD-A and ACD-B—the ACD-A formulation is widely used in research laboratories, blood banking, cell therapy, and applications requiring healthy, functional red blood cells.
The formulation contains three principal components:
Citric acid
Sodium citrate
Dextrose (glucose)
At first glance, the recipe appears surprisingly simple.
However, each ingredient performs a specific function, and together they create an environment that both prevents coagulation and helps preserve red blood cell viability.
The star of the formulation is citrate.
Citrate is a naturally occurring organic acid best known as an intermediate of the citric acid cycle (also known as the Krebs cycle), the metabolic pathway responsible for generating cellular energy in aerobic organisms.
You may be wondering why a molecule involved in cellular respiration is added to a blood collection tube.
The answer is that citrate performs a completely different function in ACD-A than it does inside our cells.
Instead of participating in energy metabolism, citrate acts as a chelating agent.
Chelation refers to the ability of certain molecules to bind metal ions very tightly.
When blood enters an ACD-A tube, citrate rapidly binds free calcium ions circulating in the plasma.
The calcium itself has not disappeared.
Instead, it becomes locked within stable calcium-citrate complexes that are no longer available to support coagulation.
Because the concentration of free calcium falls dramatically, the coagulation factors can no longer assemble into the enzyme complexes required for clot formation.
The clotting cascade effectively stalls before significant thrombin can be generated.
As a result, fibrin never develops, and the blood remains fluid.
One of the advantages of citrate is that this process is largely reversible.
Unlike anticoagulants that permanently alter clotting proteins, citrate simply removes calcium from circulation temporarily. If calcium is added back under controlled laboratory conditions, normal coagulation can often be restored.
This reversible mechanism explains why citrate-based anticoagulants are widely used not only in malaria research but also in blood banking, platelet collection, coagulation testing, and cellular therapies, where preserving the physiological properties of blood cells is essential.
Preventing clotting, however, is only part of the story.
Even after coagulation has been halted, red blood cells remain living cells.
Keeping them alive presents another challenge altogether.
Why Does ACD-A Also Contain Dextrose?
At this point, you might be wondering something.
If citrate has already prevented blood from clotting, why does ACD-A contain glucose?
After all, once blood has been collected, aren't red blood cells essentially inactive?
Not at all.
Although mature human erythrocytes lack a nucleus, mitochondria, ribosomes, and most other intracellular organelles, they are very much alive.
Red blood cells continuously consume energy throughout their approximately 120-day lifespan in the circulation.
Unlike most cells in the body, however, erythrocytes cannot generate ATP through oxidative phosphorylation because they lack mitochondria.
Instead, they rely entirely on glycolysis.
Every molecule of glucose entering a red blood cell is metabolised through the glycolytic pathway, producing a modest amount of ATP.
While glycolysis is far less efficient than mitochondrial respiration, it generates enough energy to maintain the specialised functions of the erythrocyte.
So what exactly is all this ATP used for?
One of its most important roles is powering the sodium-potassium pump (Na⁺/K⁺-ATPase).
This membrane protein continuously transports sodium ions out of the cell while bringing potassium ions back inside.
Maintaining these ion gradients is essential for regulating cell volume, membrane integrity, and osmotic balance.
ATP is also required to maintain the remarkable flexibility of the red blood cell membrane.
A typical erythrocyte measures approximately 7–8 μm in diameter, yet many capillaries are only 3–5 μm wide.
To pass through these tiny blood vessels, red blood cells must repeatedly deform, fold, and recover their characteristic biconcave shape without rupturing.
This extraordinary deformability depends on an intact membrane skeleton composed of proteins such as spectrin, ankyrin, and actin, together with ATP-dependent processes that preserve membrane architecture.
When ATP levels begin to fall, these systems gradually fail.
Ion pumps become less efficient.
Sodium accumulates inside the cell.
Water follows by osmosis.
The membrane loses its flexibility and stability.
As the cytoskeleton deteriorates, the erythrocyte becomes increasingly rigid and fragile.
Eventually, red blood cells may undergo haemolysis, releasing haemoglobin into the surrounding plasma, or they simply become poor host cells for Plasmodium falciparum.
This has important implications for malaria culture.
The parasite does not efficiently invade dead or severely damaged erythrocytes.
Successful invasion depends upon healthy red blood cells with intact membranes, normal biochemical activity, and sufficient deformability to support intracellular parasite development.
By supplying glucose, the dextrose component of ACD-A helps sustain glycolysis after blood collection.
This allows erythrocytes to continue producing ATP, slowing the biochemical deterioration that naturally occurs once blood has been removed from the circulation.
In simple terms, citrate keeps the blood fluid.
Dextrose helps keep the red blood cells alive.
Why Is the Formulation Acidic?
The final component of ACD-A is hidden in its very name.
The A stands for Acid.
Why deliberately make a blood preservative acidic?
The answer lies in cellular metabolism.
Even after blood collection, every cell in the specimen continues carrying out biochemical reactions.
Red blood cells continue consuming glucose.
White blood cells remain metabolically active.
Platelets continue responding to their environment.
Over time, these metabolic processes consume nutrients, alter pH, and gradually reduce specimen quality.
Lowering the pH slows many enzyme-catalysed reactions within cells.
In effect, the acidic environment gently reduces cellular metabolism without killing the cells.
You can think of it as placing food in a refrigerator.
Cooling food does not stop bacterial growth entirely, but it slows biological activity enough to extend freshness.
Similarly, the mildly acidic environment created by ACD-A slows metabolic deterioration, helping preserve red blood cells for downstream laboratory applications.
When combined, the three components of ACD-A work remarkably well as a team.
Citrate prevents coagulation by temporarily removing calcium from the clotting cascade.
Dextrose provides the glucose required for continued ATP production through glycolysis.
Acidification slows cellular metabolism, helping preserve blood cell integrity during storage.
Together, these components transform what would otherwise become a clot into a specimen that remains suitable for research applications such as Plasmodium falciparum culture.
Of course, even the best anticoagulant can only work properly if the blood is collected correctly.
Why Laboratories Use ACD-A Blood Collection Tubes
Understanding the chemistry of ACD-A is only part of obtaining a high-quality blood specimen.
The next challenge is ensuring that the anticoagulant is present in exactly the right proportion.
Too little anticoagulant, and blood begins to clot.
Too much anticoagulant, and the chemical environment surrounding the red blood cells changes, potentially affecting their physiology and downstream applications.
This is where evacuated blood collection tubes become invaluable.
Modern blood collection systems, such as BD Vacutainer ACD-A Blood Collection Tubes, are carefully engineered to collect a predetermined volume of blood while containing a precisely measured amount of anticoagulant. The vacuum inside the tube automatically draws blood until the intended fill volume is reached, ensuring a consistent anticoagulant-to-blood ratio from one collection to the next.
Although this may seem like a simple engineering feature, it greatly improves standardisation between specimens.
Imagine collecting blood into an ordinary tube and manually adding anticoagulant each time. Even small pipetting errors or variations in blood volume could change the final anticoagulant concentration, introducing unnecessary variability between experiments.
By standardising both the blood volume and the amount of ACD-A, evacuated blood collection tubes minimise this source of variation and help laboratories obtain reproducible, high-quality specimens.
This consistency is especially important in malaria research, where subtle differences in red blood cell physiology can influence parasite invasion, growth, and experimental outcomes.
Why Filling the Tube Completely Matters
One of the most common specimen collection errors is underfilling the blood collection tube.
At first glance, a partially filled tube may appear perfectly acceptable.
After all, the blood is still liquid.
The tube still contains anticoagulant.
So why should a few millilitres matter?
The answer comes back to chemistry.
Every ACD-A blood collection tube contains a fixed amount of anticoagulant that has been carefully calculated for a specific volume of blood.
When the tube fills completely, the intended anticoagulant-to-blood ratio is achieved.
If the tube is only partially filled, the amount of anticoagulant remains the same, but the amount of blood decreases.
As a result, the concentration of citrate becomes proportionally higher than intended.
Excess citrate can alter the ionic environment surrounding red blood cells and may influence downstream laboratory procedures that depend on normal physiological conditions.
The opposite problem can also occur.
If more blood is collected than the tube was designed to accommodate, there may be insufficient citrate available to chelate all of the free calcium ions.
This increases the likelihood of incomplete anticoagulation and clot formation.
For this reason, blood collection tubes should always be allowed to fill until the vacuum is exhausted. Doing so ensures that the correct ratio of anticoagulant to blood is achieved, preserving specimen quality for downstream applications.
Why Immediate Mixing Is So Important
Blood coagulation does not wait for the phlebotomist to finish the procedure.
The moment blood enters the collection tube, the coagulation cascade has the potential to begin.
Fortunately, the ACD-A anticoagulant is already present inside the tube.
The only requirement is to distribute it evenly throughout the specimen as quickly as possible.
This is why blood collection guidelines recommend gently inverting the tube immediately after collection.
Notice the word gently.
The purpose of inversion is simply to allow the blood and anticoagulant to mix uniformly.
Shaking the tube vigorously is neither necessary nor desirable.
Excessive agitation subjects erythrocytes to mechanical stress as they repeatedly collide with one another and with the walls of the tube. This mechanical trauma can damage cell membranes, increasing the risk of haemolysis.
Instead, gentle inversion allows the anticoagulant to disperse evenly while preserving the structural integrity of the red blood cells.
The BD Vacutainer Instructions for Use recommend gently inverting ACD-A tubes 8–10 times immediately after collection to ensure complete mixing of blood with the anticoagulant. This simple step takes only a few seconds but plays a critical role in preserving specimen quality.
Why Clots Are a Serious Problem
Sometimes a blood specimen appears perfectly normal when viewed with the naked eye.
The blood remains liquid.
There is no obvious clot.
Everything seems fine.
Yet microscopic strands of fibrin may already be forming.
These small clots often go unnoticed during collection but can create significant problems later during laboratory processing.
Fibrin acts like a biological mesh, trapping red blood cells within an insoluble network.
Every erythrocyte trapped inside that mesh is one less cell available for parasite culture.
Clots also make washing procedures less efficient and reduce the consistency of cell recovery between experiments.
Even if only a small proportion of the specimen has clotted, the resulting variability may affect parasite growth, invasion assays, erythrocyte invasion efficiency, or other downstream analyses.
For these reasons, laboratory personnel carefully inspect every specimen before processing.
High-quality specimens should be correctly labelled, collected into the appropriate tube, filled to the intended volume, mixed immediately after collection, and free from leakage or clot formation. Conversely, specimens showing incorrect identification, underfilling, inadequate mixing, clotting, leakage, or damaged collection tubes should be rejected before they enter the laboratory workflow.
Storage: Preserving Red Blood Cells After Collection
Collecting an excellent specimen is only the first step.
How the blood is stored afterwards is equally important.
Even though ACD-A prevents coagulation and helps preserve erythrocyte metabolism, it cannot stop biological ageing completely.
From the moment blood leaves the donor, red blood cells begin undergoing gradual biochemical and structural changes.
Scientists refer to these cumulative changes as the red blood cell storage lesion.
As storage time increases, ATP levels decline, membrane lipids and proteins undergo oxidative damage, ion gradients become disrupted, and the membrane gradually loses its remarkable flexibility.
These changes make erythrocytes progressively less like the healthy cells circulating inside the human body.
For malaria researchers, this matters because Plasmodium falciparum has evolved to invade healthy human erythrocytes.
Changes in membrane deformability, surface receptors, intracellular metabolism, or overall cell integrity can all influence parasite invasion and development.
Although ACD-A significantly slows these changes, it cannot prevent them indefinitely.
For this reason, blood should be processed as soon as practical after collection, while storage conditions should follow both the manufacturer's recommendations and the requirements of the downstream application. Proper handling after collection is just as important as proper collection itself.
The Bigger Picture
At first glance, collecting blood into an ACD-A tube appears to be one of the simplest procedures performed in a malaria laboratory.
A needle is inserted.
The tube fills.
The blood is mixed.
The specimen is stored.
The entire process takes only a few minutes.
Yet beneath this seemingly routine procedure lies an extraordinary amount of biology and chemistry.
Within seconds of blood entering the tube, citrate begins binding calcium ions, preventing the coagulation cascade from producing fibrin. Dextrose provides the glucose required to sustain ATP production through glycolysis, while the mildly acidic environment slows cellular metabolism and helps preserve erythrocyte integrity.
Each component contributes to maintaining healthy red blood cells that can later support Plasmodium falciparum invasion and growth.
Understanding this chemistry transforms blood collection from a routine laboratory task into the very first quality control step of every malaria culture experiment.
Researchers often focus on culture media, incubator conditions, gas composition, synchronisation methods, or parasite strains when troubleshooting poor parasite growth.
However, successful cultures frequently depend on decisions made long before parasites ever enter the incubator.
Was the correct anticoagulant used?
Was the blood collected properly?
Was the tube filled completely?
Was it mixed immediately?
Was the specimen stored appropriately?
These seemingly simple questions often determine the quality of the red blood cells that ultimately support parasite growth.
Every successful malaria culture begins not in the incubator, but at the moment the first drop of blood enters the collection tube.
Related Reading
How to Isolate Red Blood Cells for Plasmodium falciparum Culture: Protocol, History, and What Your Tube Is Actually Doing — Now that you understand why ACD-A preserves your blood specimen, see the full step-by-step isolation protocol that puts this chemistry into practice, including the centrifugation, washing, and haematocrit steps that follow collection.
https://adwoabiotech.blogspot.com/2026/04/rbc-isolation-plasmodium-falciparum-culture%20.html
You may also enjoy:
The History of Giemsa Stain: How Methylene Blue and Eosin Impacted Malaria Diagnosis: https://adwoabiotech.blogspot.com/2026/03/what-is-giemsa-stain-chemistry-history.html
Learn about the complete parasite life cycle from mosquito to human and back again. Understanding the biology helps you interpret what you're seeing under the microscope: Understanding the Life Cycle of Plasmodium falciparum:
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments